Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids.
GoodRx reports that Medicare's new GLP-1 Bridge program allows eligible Part D enrollees to access weight-loss medications ...
For decades, it's been against the law for Medicare to pay for weight-loss medication. But that changed on July 1, with the ...
It is time for the state administration to step up to the plate and finally agree to adequately staff, and continue to staff, ...
A new Medicare bridge program allows some older Americans on Part D to receive select GLP-1 weight loss medications for $50 ...
New Jersey is launching a new fee on companies whose workers have Medicaid health coverage instead of being covered by their ...
Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...
Medicare has started covering obesity drugs for the first time – and companies like Walmart and CVS Health are playing an ...
The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.
The Centers for Medicare & Medicaid Services July 1 issued its calendar year 2027 proposed rule for the home health prospective payment system. The rule proposes a 2.4% update, which includes a 3.1% ...
The Centers for Medicare & Medicaid Services July 1 launched the Medicare GLP-1 Bridge, a short-term demonstration program designed to provide eligible Medicare Part D beneficiaries with access to ...
Major Social Security changes have taken place in 2026, and new shifts are coming in 2027. Learn what's happened so far this year and what's in store.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results